Blue Fin Capital, Inc. reports 23.50% decrease in ownership of BRM / Bristol-Myers Squibb Company

Bristol-Myers Squibb Company

DE ˙ XTRA ˙ US1101221083

47,43 € ↓ -0,01 (-0,01%)

2026-06-04
DEL PRIS

Security	DE:BRM / Bristol-Myers Squibb Company
Institution	Blue Fin Capital, Inc.
Latest Disclosed Ownership	5,245 shares
Latest Disclosed Value	$ 318,134

On May 28, 2026 - Blue Fin Capital, Inc. filed a 13F-HR form disclosing ownership of 5,245 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $274,943 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 23, 2026 disclosing 6,856 shares of Bristol-Myers Squibb Company. This represents a change in shares of -23.50% during the quarter. The current value of the position is $248,770 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel Premium Registration Required .

Disclosed Equity Positions (from 13F/NPORT Filings)

File Date	Effective Date	Form	Security	Class	ID	Reported Shares	ΔShares	ΔShares (%)	Reported Value (x1000)	ΔValue (%)	Alloc (%)
2026-05-28	2026-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	5,245	-1,611	-23.50	318	-13.82	0.0522
2026-01-23	2025-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	6,856	-283	-3.96	370	14.95	0.0574
2025-11-21	2025-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,139	-74	-1.03	322	-3.60	0.0506
2025-08-13	2025-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,213	0	0.00	334	-24.15	0.0568
2025-11-21	2025-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,213	-61	-0.84	440	6.81	0.0853
2025-02-18	2024-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,274	-32	-0.44	411	8.73	0.0758
2024-11-05	2024-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,306	0	0.00	378	24.75	0.0718
2024-07-31	2024-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,306	0	0.00	303	-23.48	0.0606
2024-05-14	2024-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,306	-573	-7.27	396	-1.98	0.0883
2024-02-06	2023-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,879	-41	-0.52	404	-11.98	0.1038
2023-10-19	2023-09-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	7,920	-109	-1.36	460	-10.53	0.1342
2023-07-31	2023-06-30	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,029	0	0.00	513	-4.29	0.1466
2023-05-12	2023-03-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,029	-249	-3.01	536	-9.92	0.1733
2023-01-23	2022-12-31	13F	BRISTOL-MYERS SQUIBB	COM	110122108	8,278	-26	-0.31	596	0.85	0.2182
2022-11-04	2022-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	8,304	0	0.00	590	-7.67	0.2229
2022-08-08	2022-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	8,304	-168	-1.98	639	3.40	0.2262
2022-04-12	2022-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	8,472	-36	-0.42	618	16.60	0.1791
2022-01-19	2021-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	8,508	-350	-3.95	530	1.15	0.1468
2021-10-25	2021-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	8,858	-297	-3.24	524	-14.24	0.1600
2021-07-19	2021-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	9,155	-320	-3.38	611	2.17	0.1882
2021-05-05	2021-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	9,475	-110	-1.15	598	0.67	0.2049
2021-01-28	2020-12-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	9,585	-214	-2.18	594	0.68	0.2126
2020-10-28	2020-09-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	9,799	-256	-2.55	590	-0.17	0.2387
2020-08-10	2020-06-30	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	10,055	-1,325	-11.64	591	-6.78	0.2616
2020-04-28	2020-03-31	13F	BRISTOL-MYERS SQUIBB CO COM	COM	110122108	11,380	-493	-4.15	634	-16.80	0.3499
2020-02-10	2019-12-31	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	11,873	0	0.00	762	26.58	0.3590
2019-11-07	2019-09-30	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	11,873	-1,197	-9.16	602	1.69	0.3152
2019-07-22	2019-06-30	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	13,070	-225	-1.69	592	-6.62	0.3050
2019-04-23	2019-03-31	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	13,295	-84	-0.63	634	-8.78	0.3329
2019-01-16	2018-12-31	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	13,379	-1,331	-9.05	695	-23.88	0.4151
2018-12-27	2018-09-30	13F/A-2	BRISTOL MYERS SQUIBB CO COM	COM	110122108	14,710	-1,475	-9.11	913	2.01	0.4522
2018-11-09	2018-09-30	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	14,710	-1,475		913
2018-12-31	2018-06-30	13F/A-2	BRISTOL MYERS SQUIBB CO COM	COM	110122108	16,185	-1,340	-7.65	895	-19.22	0.4782
2018-08-06	2018-06-30	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	16,185	-1,340		896
2018-05-07	2018-03-31	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	17,525	380	2.22	1,108	5.42	0.6257
2018-01-26	2017-12-31	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	17,145	-230	-1.32	1,051	-5.06	0.6123
2017-10-11	2017-09-30	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	17,375	-150	-0.86	1,107	13.42	0.6786
2017-08-02	2017-06-30	13F	BRISTOL MYERS SQUIBB CO COM	COM	110122108	17,525	-1,105	-5.93	976	-3.65	0.6279
2017-05-01	2017-03-31	13F	Bristol-Myers Squibb	COM	110122108	18,630	-25	-0.13	1,013	-7.15	0.6206
2017-02-02	2016-12-31	13F	Bristol-Myers Squibb	COM	110122108	18,655	2,270	13.85	1,091	23.56	0.7213
2016-10-21	2016-09-30	13F	Bristol-Myers Squibb	COM	110122108	16,385	250	1.55	883	-25.61	0.7157
2016-07-29	2016-06-30	13F	Bristol-Myers Squibb	COM	110122108	16,135	-325	-1.97	1,187	12.94	0.9844
2016-04-14	2016-03-31	13F	Bristol-Myers Squibb	COM	110122108	16,460	-885	-5.10	1,051	-11.90	0.8949
2016-01-07	2015-12-31	13F	Bristol-Myers Squibb	COM	110122108	17,345	-180	-1.03	1,193	15.04	0.9190
2015-10-13	2015-09-30	13F	Bristol-Myers Squibb	COM	110122108	17,525	-370	-2.07	1,037	-12.93	0.8070
2015-07-23	2015-06-30	13F	Bristol-Myers Squibb	COM	110122108	17,895	0	0.00	1,191	3.21	0.8571
2015-04-06	2015-03-31	13F	Bristol-Myers Squibb	COM	110122108	17,895	-20	-0.11	1,154	9.07	0.8332
2015-01-09	2014-12-31	13F	Bristol-Myers Squibb	COM	110122108	17,915	520	2.99	1,058	18.88	0.7976
2014-11-06	2014-09-30	13F	Bristol-Myers Squibb	COM	110122108	17,395	375	2.20	890	7.75	0.7057
2014-07-29	2014-06-30	13F	Bristol-Myers Squibb	COM	110122108	17,020	700	4.29	826	-2.59	0.6620
2014-05-13	2014-03-31	13F	Bristol-Myers Squibb	COM	110122108	16,320	-877	-5.10	848	-7.22	0.7473
2014-02-07	2013-12-31	13F	Bristol-Myers Squibb	COM	110122108	17,197	17,197		914		0.8143

Legend

Shares: The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value: The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price: The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class: This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred

Allocation (%): The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation: The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%): The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis: The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss: This is the market value of the position as of the effective date minus the cost basis.